Jose Muñoz Aycart, Co-founder of Wondermed, joins Paul F. Austin to discuss revolutionizing mental health through at-home ketamine treatments.

Find episode links, summary, and transcript here.

As Co-founder at Wonder Sciences, Wondermed’s parent company, Jose Muñoz Aycart combines his experience in international economics and astrophysics to build the Wondermed ecosystem, empowering people’s inner healer by providing affordable, personalized, evidence-based resources.

Having previously built self-sustained desalination plants in underdeveloped countries, Jose has shifted his focus to healing mental-health disorders with the power of psychedelic medicine, helping raise the $5.6M seed round that made Wonder Sciences possible.

His goal is to continue pushing the boundaries of our imagination through innovation.

Highlights:

• How Jose applies his diverse background to psychedelics.
• Wondermed’s goal of “empowering the healer” through accessible, affordable treatment.
• The essential resources Wondermed offers its clients in addition to ketamine treatments.
• Jose’s own psychedelic experiences, which confirmed perspectives arrived at from studying astrophysics and philosophy.
• The power of expanding our perspective.
• “Ketatations” and the role of ketamine in group contexts.
• Who is eligible for Wondermed’s ketamine services and why.
• Wondermed’s plans to support the psychedelic community as legalization and public acceptance progress.

Episode Links:

• Wonder Sciences
• Wondermed
• Wondermed on Instagram
• Jose on LinkedIn

This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

This podcast is brought to you by Third Wave's Mushroom Grow Kit. Get the tools you need to grow mushrooms along with an in-depth guide to finding spores.

Paul F. Austin hosts a panel discussion on advocacy for legalizing microdosing, and why it matters in the psychedelic movement.

This episode is a re-broadcast from the Into The Multiverse Podcast and was recorded in July 2022 in Los Angeles, CA, at the launch party of the Microdosing Collective, a non-profit dedicated to advancing and protecting the right to microdose. In a special panel discussion hosted by Paul F. Austin, four passionate leaders in the world of psychedelics discuss topics such as the history of microdosing, sacred rituals, the legal landscape, and how to safely advocate for microdosing. This discussion is a rebroadcast and was originally released on the Into The Multiverse Podcast

About the panelists:

Alli Schaper Alli Schaper is an entrepreneur, community builder, speaker, mental-wellness advocate, and enthusiast for mushrooms and other psychedelic medicines. She is currently the CEO & Co-Founder of Into The Multiverse, an education-first ecosystem for all things fungi, whose mission is to rebrand functional mushrooms and encourage collaboration in the psychedelics industry. Her team has created the world's first functional mushroom marketplace, The Multiverse, and SuperMush, their in-house consumer lifestyle brand.

Her passion for bringing microdosing psychedelics to the mainstream wellness conversation led her to collaboratively launch The Microdosing Collective. She is also the host of Into The Multiverse Podcast. Instagram: @allischaper

Marie Mbouni, M.D. Born in Cameroon, Africa, Marie Mbouni, M.D. felt a calling toward healing and was initiated into iboga at the age of 14. Ultimately she would go on to pursue her education in Canada and the United States, following the Western medical route as an anesthesiologist. After years in this profession, Marie realized it did not fully align with her vision of healing and embraced a new career as a shaman, energy healer, and mentor. Marie has studied and cared for the body for over 20 years. Opening herself to the power of the mind, the beauty of intuition, and the all-encompassing power of love changed her, she stepped into her destiny as a healer and embraced her potential beyond the confines of the mainstream. Instagram: @mariembounimd

Joshua Kappel Joshua Kappel is a founding partner of Vicente Sederberg with a practice devoted to helping entrepreneurs and like-minded professionals build human-centric and regenerative companies in the cannabis and psychedelic communities. Joshua also has a passion for helping advocates draft legislation and build sustainable legal vehicles that will  influence these emerging industries going forward.

Recently, Mr. Kappel was a co-author and chair of the campaign committee for Colorado’s Proposition 122, which was the first successful state ballot measure to create access to natural psychedelic healing through both a state-regulated and a decentralized community-healing model. Joshua also helped draft Denver’s psilocybin decriminalization initiative and has assisted in drafting cannabis and psychedelic measures across the country for over 12 years.

Paul F. Austin (Host) Paul F. Austin is a 21st-century pioneer of the responsible use of psychedelics for healing, leadership, and personal transformation. He has been featured in Rolling Stone, the New York Times, and WebMD for his work amplifying awareness around the benefits of microdosing psychedelics. Paul is the author of the book Mastering Microdosing: How to Use Sub-Perceptual Psychedelics to Heal Trauma, Improve Performance, and Transform Your Life and the founder of two companies in the emerging psychedelic space, Third Wave and Synthesis. Instagram: @paulaustin3w

Highlights:

• Why microdosing advocacy matters.
• A brief history of microdosing and its potential role in mainstream acceptance of psychedelics.
• Panelists share their “why” in promoting responsible psychedelic use in mainstream society.
• On sacred reciprocity and microdosing with plant medicines.
• The current legal landscape of microdosing and the work ahead towards legalization.
• Harnessing neuroplasticity for wellness and optimization.
• Drawing on lessons from cannabis when it comes to microdosing psychedelics.
• How to share support for microdosing without putting yourself at risk.
• Defining microdosing.

Episode Links:

• Microdosing Collective Website
• Book, The Psychedelic Explorer’s Guide by James Fadiman
• Book, Drug Use for Grown-Ups by Dr. Carl L. Hart

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

This episode is brought to you by Third Wave’s Coaching Certification Program. This is an opportunity for coaches with existing practices to be a part of a movement that will change lives.

This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

Paul F. Austin is joined by BJ Miller, M.D., co-founder of Mettle Health, for a discussion on psychedelics and living and dying well.

Find episode links, summary, and transcript here.

BJ Miller, M.D. is an established thought leader in the area of serious illness, end-of-life issues, and dying. He has been a physician for 19 years and has counseled over 1,000 patients and family members. This vast experience has led him to understand what people really need when dealing with difficult health situations.

BJ has given over 100 talks, both nationally and internationally, on the themes of serious illness and dying, He has given over 100 media interviews, including podcasts, radio, and print. His TED Talk, What Really Matters at the End of Life has been viewed over 11 million times. He is co-author of the book, A Beginner’s Guide to the End: Practical Advice for Living Life and Facing Death, published in 2019.

Highlights:

• Powerful insights and perspectives from BJ’s work in palliative and end-of-life care.
• From taboo to opportunity: examining attitudes towards death across cultures and history.
• How BJ became involved in the intersection of psychedelics and end-of-life.
• Looking at the data on psychedelic therapy for patients with end-of-life anxiety.
• “Anesthetics vs. Aesthetics”: BJ’s insights into a helpful set and setting for dying well.
• Embracing regret and fear at the end of life.
• The power of love—during life and at the time of death.
• Mettle Health, BJ’s service for patients and caregivers.

Episode Links:

• Mettle Health
• Zen Hospice Project
• BJ Miller's TED Talk, "What really matters at the end of life"
• Ep. 136 - Jeremy Narby, Ph.D.: “More Than Molecules”: Plants as Living Teachers
• Presentation by Dr. BJ Miller & Dr. Justin Burke: "Exploring the Aesthetic Dimension of End-of-Life Care”
• Mettle Health on Youtube
• Mettle Health on Instagram
• Mettle Health on Twitter
• BJ Miller on Twitter

This podcast is brought to you by Third Wave's Mushroom Grow Kit. Get the tools you need to grow mushrooms along with an in-depth guide to finding spores.

This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

James Ravenhall of NewTerritory joins Paul F. Austin to discuss how design thinking can be used to bring innovation to psychedelics & vice versa.

James Ravenhall is Creative Director of NewTerritory design studios. He talks about the studio’s visionary microdosing platform concept, “Human Nature,” and how products like it might shift cultural perceptions of psychedelics. Paul and James envision new approaches to psychedelic experiences through the lens of design thinking.

Find episode links, summary, and transcript here.

Originally a trained chef, James spent a number of years working in kitchens in London and Paris before earning his Bachelor’s degree in Industrial Product Design. Now, he has over thirteen years’ experience leading engagements in brand strategy, product, spatial, service, and digital for some of the world’s most impactful brands across the automotive, aviation, and space travel industries. James has an innate passion to work alongside people who see design not just as a tool, but as a platform to make a positive impact and effect real change for people, planet. and profit.

Instagram - @newterritorydesign

Website - www.newterritory.io

Highlights:

• James shares about his human-centered approach to design and how psychedelics are influencing his work.
• The triple bottom line, “People-Planet-Profit,” and the guiding principles of James’s work.
• James unpacks his creative process and what inspires new projects in his studio. “Human Nature” — a tailored microdosing platform concept that aims to shift public perception and influence legislation.
• Using design thinking to envision how microdosing can be integrated into daily life.
• Applying James’s approach to rethinking high-dose psychedelic experiences and ways to personalize experiences.
• Gourmet dining in space and other projects James is working on.

Episode Links:

• NewTerritory
• “Human Nature” — James’s microdosing product concept
• Transcendental Meditation
• THE WELL New York
• Article, “Could Psychedelics Help To Heal The Crisis of Disconnection?” by Sam Gandy, Rosalind Watts and Alex Evans
• Synthesis Institute
• Wavepaths

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

This episode is brought to you by Third Wave’s Coaching Certification Program. This is an opportunity for coaches with existing practices to be a part of a movement that will change lives.

This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

Paul F. Austin welcomes Ryan Sprague, founder of Highly Optimized, who shares how to cultivate a positive relationship with cannabis & more.

Find episode links, summary, and transcript here.

Ryan is the founder and co-owner of Highly Optimized, a company dedicated to helping its clients transform and become the conscious leaders the world is patiently awaiting. He is also the host of the “Highly Optimized” Podcast, the “This One Time On Psychedelics” Podcast and is the creator of the “Connect With Cannabis” program & the “Grow With Cannabis” course.

Ryan’s mission in life is helping his fellow brothers and sisters become empowered in their experience of being alive through one-on-one men’s coaching, plant medicine integration coaching and retreat experiences.

In this episode, Ryan shares powerful life-learned wisdom and insights for developing a healthy relationship with cannabis, and goes deep into the science behind different cannabis strains, compounds and routes of administration.

Connect with Ryan on Instagram @therealryansprague and @highly.optimized

Highlights:

• Joint vs. Spliff: cultivating healthy relationships with both tobacco and cannabis.
• Ryan’s use of cannabis to treat generalized anxiety disorder that began a path of deepening connection with the plant.
• Ryan’s powerful experiences at the end of his father’s life that gave him a life calling with cannabis.
• Ryan’s intentional reentry into cannabis use that led to the creation of his coaching program, Connect With Cannabis.
• Methods, tools and information for having safe and effective psychedelic experiences with cannabis.
• Exploring the unique effects of different routes of cannabis administration—from edibles to boofing.
• The psychoactive effects of cannabinoids vs. terpenes.
• Ryan’s advice on establishing an intentional relationship with cannabis.

Episode Links:

• Ryan’s website, Highly Optimized
• Conscious Cannabis Guide
• Highly Optimized Podcast
• This One Time On Psychedelics Podcast
• Ryan’s podcast episode with Paul as guest: Episode 82: Leading The Charge In Psychedelic Education
• Highly Optimized Ceremony Circle Facebook Group
• Third Wave’s Ultimate Guide to Cannabis
• Studies on the effect of THC on cancer cells in mice
• EndoDNA cannabis testing service
• Hemp Lucid CBD Oil
• Episode 131: John Lieurance
• ACE Seeds

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

This podcast is brought to you by Third Wave's Mushroom Grow Kit. Get the tools you need to grow mushrooms along with an in-depth guide to finding spores.

Paul Austin is joined by Dr. Suresh Muthukumaraswamy, lead researcher in the world's first LSD microdosing clinical trial.

Find episode links, summary, and transcript here.

This is another special interview recorded on location at the 2022 Wonderland Conference in Miami, FL. Dr. Muthukumaraswamy shares the unique design of his LSD microdose trial, plans for future research, and how these studies might be received in New Zealand and around the globe.

Suresh completed his Ph.D. in psychology at the University of Auckland in 2005 after which he joined the newly established Cardiff University Brain Research Imaging Centre as a postdoctoral fellow. In 2014, Suresh received a Rutherford Discovery Fellowship and has returned to Auckland where he works in The School of Pharmacy (Faculty of Medicine and Health Sciences).

Suresh’s main research interests are in understanding how therapies alter brain activity and in developing methodologies to measure these changes in both healthy individuals and patient groups - particularly patients with depression. His previous studies have involved a range of compounds including hallucinogens (ketamine, LSD, psilocybin), anesthetics (propofol, dexmedetomidine), anti-epileptics (vigabatrin, perampanel, tiagabine) and GABA-enhancers (zolpidem, gaboxadol). Suresh’s research has used a wide-range of neuroimaging techniques including magnetoencephalography, electroencephalography, functional magnetic resonance imaging and magnetic resonance spectroscopy.

Highlights:

• Dr. Muthukumaraswamy shares his academic and professional background, and what led him to studying psychedelics.
• Dr. Muthukumaraswamy explains the origin story and unique design of his LSD microdosing study.
• How study volunteers generally respond to microdosing in a lab vs. in their normal daily environments.
• Design elements Dr. Muthukumaraswamy plans to implement in future LSD microdose studies.
• Considering how Dr. Muthukumaraswamy’s take-home LSD microdose study might impact research and policy in other countries.
• The legal landscape of psychedelics relevant to New Zealand’s indigenous Māori community.

Episode Links:

• Protocol for Dr. Muthukumaraswamy’s LSD microdose study
• Suresh’s lab, Auckland Neuro- Psycho- Pharmacology Research Group on Facebook
• Scopolamine, “Devil’s Breath”
• Ep. 172: Paul Stamets & Pamela Kryskow, M.D. - The Future of Microdosing: Legislation, Research, & Science
• Ep. 107: Mendel Kaelen - Music and Psychedelic Medicine: Healing Through Sound

This podcast is brought to you by Third Wave's Mushroom Grow Kit. Get the tools you need to grow mushrooms along with an in-depth guide to finding spores.

This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

Matthew W. Johnson, Ph.D. joins Paul F. Austin to share his studies of psilocybin for smoking cessation, cancer distress treatment, and more

In this episode, we feature another special interview recorded at the 2022 Wonderland conference in Miami, FL.

Find episode links, summary, and transcript here.

Matthew W. Johnson, Ph.D. is the Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world’s most widely published experts in the field. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021, as principal investigator, he received the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in the treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes.

Highlights:

• How Dr. Johnson’s own life has changed as a result of his years of research, including psilocybin for the treatment of cancer distress.
• Dr. Johnson’s study on psilocybin for smoking cessation; the first US government-funded study on the therapeutic use of a psychedelic in 50 years.
• The initial findings of psilocybin vs. nicotine patch as smoking-cessation treatments.
• How Dr. Johnson plans to contribute to psychedelic research and oversight as the industry grows.
• Dr. Johnson cautions psychedelic therapists against inappropriately pushing spiritual or religious frameworks onto patients.

Episode Links:

• Dr. Johnson on Google Scholar
• Dr. Johnson on Twitter
• Dr. Johnson’s smoking cessation study on ClinicalTrials.gov
• Dr. Johnson’s paper, “Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine”
• Book, The Perennial Philosophy by Aldous Huxley
• Book, The Immortality Key by Brian Muraresku

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

Rick Doblin, Ph.D., founder of MAPS, joins Paul F. Austin to discuss the healing of humanity through legalized psychedelic medicine.

This is another special interview from the 2022 Wonderland Conference in Miami, FL. Paul F. Austin is joined by MAPS founder Rick Doblin, Ph.D., to discuss the healing of humanity through legalized psychedelic medicine.

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana. His Master’s thesis was a survey of oncologists on smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. Learn more about Rick by listening to his Origin Story and watching his TED Talk.

Highlights:

• Rick Doblin’s life (in five minutes), the origin story of MAPS, and the latest progress of its FDA clinical trials.
• How MAPS has changed since Michael Pollan’s How To Change Your Mind Netflix documentary.
• What keeps Rick focused, grounded and motivated to continue his work.
• Why MAPS chose to work with MDMA for PTSD, and what its strategy will look like after FDA approval.
• The novel financing strategies MAPS is taking in response to the ‘failure of philanthropy’.
• Working towards mass mental health and a “global spiritualized humanity”.
• MAPS’ Fourth Psychedelic Science Conference — June 2023.
• How to “make a post-prohibition world work out” and empower people to deal with trauma, with and without substances.

Episode Links:

• MAPS
• MAPS Public Benefit
• Michael Pollan’s How To Change Your Mind Netflix documentary
• Peter Jennings’ documentary, Ecstasy Rising
• ICPR Conference
• Maslow's hierarchy of needs
• Book, The Religion of Tomorrow by Ken Wilber
• Book, Island by Aldous Huxley
• Ep. 154: Deborah Mash. Healing Addiction With Ibogaine: What the Research Tells Us
• 162 Dr. Andrew Weil. Way of the Future: Healing Through Integrative Medicine & Psychedelics
• MAPS’ Fourth Psychedelic Science Conference
• Santo Daime
• Zendo Project
• Rick Doblin on Twitter
• Rick Doblin on Instagram

These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.

This episode is brought to you by MycroDrops™ Powerful Micro-Elixirs made from Adaptogen and nootropic herbs and mushrooms. Get MOTIVATED, FOCUSED & GROUNDED! Use code THIRDWAVE and take $10 off your first purchase of $30 or more. Visit www.mycrodrops.com.

This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

This is an uncut interview recorded live at the 2022 Wonderland Conference in Miami, FL. Paul F. Austin is joined by renowned mycologist, author and researcher Paul Stamets, along with Pamela Kryskow, M.D., both co-founders of MycoMedica Life Sciences, PBC. They dive into all things microdosing, clinical trials, naturalistic science and patient-driven research, while exploring and honoring the wisdom of indigenous cultures around the world—and even martial arts.

Find episode links, summary, and transcript here.

Paul Stamets, speaker, author, mycologist, medical researcher and entrepreneur, is considered an intellectual and industry leader in fungi: habitat, medicinal use, and production. He lectures extensively to deepen the understanding and respect for the organisms that literally exist under every footstep taken on this path of life.

Paul’s philosophy is that “MycoDiversity is BioSecurity.” He sees the ancient Old Growth forests of the Pacific Northwest as a resource of incalculable value, especially in terms of its fungal genome. A dedicated hiker and explorer, his passion is to preserve and protect as many ancestral strains of mushrooms as possible from these pristine woodlands. His research is considered breakthrough by thought leaders for creating a paradigm shift for helping ecosystems worldwide.

Paul is the author of six books (including Mycelium Running: How Mushrooms Can Help Save the World, Growing Gourmet & Medicinal Mushrooms, and Psilocybin Mushrooms of the World). He has discovered and named several new species of psilocybin mushrooms.

Dr. Pamela Kryskow is a medical doctor with a strong interest in psychedelic medicine, mental health and chronic pain. She is a founding board member of the Canadian Psychedelic Association. She is also a part of an expert team working to give Canadians access to psilocybin at end of life.

Dr Kryskow is actively involved in research related to psilocybin, MDMA, ketamine, mental wellness and neurogenesis. She is a co-investigator on the largest microdosing study, Microdose.me, which is ongoing with 14 000+ enrolled participants.

A Clinical Instructor at University of British Columbia and Adjunct Professor at Vancouver Island University, Dr. Kryskow is also the medical lead on the Roots To Thrive Ketamine Assisted Therapy program, which treats healthcare providers with PTSD, depression, anxiety, and addiction. In real life, she loves foraging in the forest, ocean kayaking, growing kale and daydreaming in the hammock.

Highlights:

• An introduction to Paul and Pam, and their work together in researching the benefits of microdosing psilocybin.
• Tracking the history of mushroom wisdom and knowledge, from indigenous traditions to scientific research.
• How the complexity of microdosing demands new research approaches and methodologies.
• Addressing the disconnect between policy and science.
• Paul Stamets’ vision of how psychedelics can be integrated in society, and how MycoMedica is working towards it.
• How new scientific findings on psilocybin and microdosing could influence future legislation.
• Closing remarks: psychedelics, kindness, and community

Episode Links

• MycoMedica Life Sciences, PBC
• Microdose.me study
• Paul Stamets’ talk at the 2017 MAPS Psychedelic Science Conference
• The roots of ‘Two-Eyed Seeing’
• mushroomreferences.com
• Quantified Citizen App
• Paul Stamets’ Website
• Paul Stamets on Instagram
• Pamela Kryskow, M.D. on LinkedIn

This episode is brought to you by MycroDrops™ Powerful Micro-Elixirs made from Adaptogen and nootropic herbs and mushrooms. Get MOTIVATED, FOCUSED & GROUNDED! Use code THIRDWAVE and take $10 off your first purchase of $30 or more. Visit www.mycrodrops.com.

This episode is brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.

Dr. Sam Zand, Co-founder & Chief Medical Officer of Better U, joins Paul F. Austin for a rich conversation on at-home ketamine-assisted therapy.

As a practicing psychiatrist and the Chief Medical Officer of Better U, Dr. Sam Zand utilizes his expertise in neuroplasticity to help patients address the root cause of their problems and establish new ways of thinking. After initial psychedelic medicine research at Johns Hopkins University, Dr. Zand began treating patients clinically with ketamine in 2019. He now teaches psychedelic medicine rotations to psychiatry residents and medical students and is an advocate and spokesperson for the FDA-approved esketamine, Spravato. He is trained in general psychiatry, addiction recovery, and psychotherapy, and has a passion for psychedelic therapy, crisis intervention, relationship counseling, and integrated spiritual therapy. In addition to being a co-founder of Better U, Dr. Zand is also the owner and CEO of a national telepsychiatry service, Anywhere Clinic. He has merged his passions for lifestyle medicine, performance coaching, and entrepreneurship to establish platforms that build leaders and medical healers. He assisted in Crisis Intervention Training for the Las Vegas Metropolitan Police Department, helped create mental skills departments for professional sports teams and corporations, and has worked with industry leaders, corporate executives, and pro athletes. Dr. Zand is passionate about increasing education to end the stigma that surrounds mental health topics, advancing the integration of psychiatry and spirituality, and making clinically proven, innovative new therapies more accessible for all.

Find episode links, summary, and transcript here.

Highlights:

• Understanding the differences between Spravato and generic ketamine, and the role each might play in the future of psychedelic-assisted therapy.
• ‘The Skill of Psychedelics’ - looking at medicines like ketamine in the bigger picture of healing, growth, and transformation.
• Dr. Zand’s Four phases of healing: Heal, Grow, Love, Transcend
• What differentiates Better U from other telemedicine psychedelic-assisted therapy services
• Dr. Zand on effective dosing, intention-setting, and utilization of psychotherapy.
• Exploring the correlation between dissociative experience and positive transformation
• How ego actualization and ego dissolution fit into the greater path of healing and transformation.
• Transcending pathology and the disease-care model of mental healthcare to embrace the biopsychosocial-spiritual model.
• The ‘Powered by Better U’ Model of collaboration to bring beneficial ketamine treatments beyond the clinic.
• Closing

Episode Links:

• Better U
• Better Universe Foundation
• Dr. Zand on LinkedIn
• Recent clinical trial on the safety and efficacy of at-home ketamine treatments
• Third Wave’s Guide to Ketamine
• MAPS

This podcast is brought to you by Third Wave’s Mushroom Grow Kit. The biggest problem for anyone starting to explore the magical world of mushrooms is consistent access from reputable sources. That’s why we’ve been working on a simple, elegant (and legal!) solution for the past several months. Third Wave's Mushroom Grow Kit and Course has the tools you need to grow mushrooms along with an in-depth guide to finding spores.

This episode is also brought to you by Apollo Neuro, the first scientifically validated wearable that actively improves your body’s resilience to stress. Apollo engages with your sense of touch to deliver soothing vibrations that signal safety to the brain. Clinically proven to improve heart rate variability, it can actually enhance the outcomes of your other efforts like deep breathing, yoga, meditation, and plant medicine. Apollo was developed by a friend of Third Wave, Dr. David Rabin M.D Ph.D., a neuroscientist and board-certified psychiatrist who has been studying the impact of chronic stress in humans for nearly 15 years. Third Wave listeners get 15% off—just use this link.